menu
    • menu
    PHARMACOMPASS
    PHARMACOMPASS

    Grow Your Pharma Business Digitally
    X
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Sonara Health Expands Remote Methadone Treatment With $2.5M Grant

    PR NEWSWIRE

    Enforcement Report - Week of February 22, 2023

    FDA

    Video DOT Could Increase Access to Methadone Treatment and Reduce Risk

    BUSINESSWIRE

    Berkshire Biomedical Awarded NIH Research Grant for Development of COPA System

    PRNEWSWIRE

    Class 3 Recall: Martindale, Methadone 5mg Tablets / Physeptone 5mg Tablets

    GOV.UK

    Relmada Therapeutics Announces Pricing of Public Offering of Common Stock

    PR NEWSWIRE

    Notice of Amendment: List of Opioids (Part A): Buprenorphine and Methadone

    HEALTH CANADA

    FDA Approves US WorldMeds` LUCEMYRA™ (lofexidine) After Priority Review

    PR NEWSWIRE

    FDA targets anti-diarrhea pills that Penn doc calls `poor man`s methadone`

    BALTIMORESUN

    How America’s prisons are fueling the opioid epidemic

    VOX

    FDA to boost drug therapy for addicts

    NWA ONLINE

    Relmada`s Acquires Global Rights to Develop and Market Dextromethadone Treatment

    PR NEWSWIRE

    Opioid Addiction Medications in Patients Taking Benzodiazepines CNS Depressants

    FDA

    All Scientific Hands on Deck to End the Opioid Crisis

    DIRECTOS BLOG

    How Ketamine could cure depression

    DRUG TARGET REVIEW

    Relmada Announces FDA Acceptance of IND Phase 2a Clinical Trial for d-Methadone

    PR NEWSWIRE

    Relmada Therapeutics Announces Results of In Vivo Study Showing d-Methadone has Antidepressant-like Effects

    PR NEWS WIRE

    Anti-HIV pill not cost effective among U.S. drug abusers

    REUTERS

    Some Opioid Users On Methadone Have High Risk Of Relapse

    FORBES

    Martindale removes povidone in oral methadone reformulation

    IN PHARMATECHNOLOGIST

    ViiV Healthcare Announces PhII Study Results for First Two Drug

    PR NEWSWIRE

    Relmada Therapeutics Receives Health Canada Clearance to Commence Multiple Ascending Dose Study with Promising NMDA Receptor Antagonist

    PR NEWS WIRE

    Roxane`s Dolophine Hcl (Methadone Hcl) Receives Supplemental Approval in US For Opioid Withdrawal Symptoms

    FDA

    Use of Methadone to Treat Pain Ups Risk of Death, Vanderbilt University Study

    BIOSPACE

    The Drug Suboxone Could Combat the Heroin Epidemic So Why is it So Hard to get

    THE WASHINGTON POST

    Relmada Completes Multiple Ascending Dose Study of d-Methadone

    PR NEWS WIRE

    Sucampo Announces Acceptance of New Drug Submission for AMITIZA(R) (lubiprostone) by Health Canada

    SUCAMPO PHARMACEUTICALS

    Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.